748 related articles for article (PubMed ID: 17177977)
21. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
[TBL] [Abstract][Full Text] [Related]
22. Murine Langerhans cells cultured under serum-free conditions mature into potent stimulators of primary immune responses in vitro and in vivo.
Kociková A; Kolesarić A; Koszik F; Stingl G; Elbe-Bürger A
J Immunol; 1998 Oct; 161(8):4033-41. PubMed ID: 9780173
[TBL] [Abstract][Full Text] [Related]
23. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
24. Cellular and molecular mechanisms in the induction phase of contact sensitivity.
Knop J; Enk AH
Int Arch Allergy Immunol; 1995; 107(1-3):231-2. PubMed ID: 7613139
[TBL] [Abstract][Full Text] [Related]
25. Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumour.
Cavanagh LL; Sluyter R; Henderson KG; Barnetson RS; Halliday GM
Immunology; 1996 Mar; 87(3):475-80. PubMed ID: 8778036
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Langerhans cell function via blood borne factor(s).
Xie Y; Streilein JW
J Dermatol Sci; 1996 Sep; 12(3):263-74. PubMed ID: 8884532
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation.
Puttur FK; Fernandez MA; White R; Roediger B; Cunningham AL; Weninger W; Jones CA
J Immunol; 2010 Jul; 185(1):477-87. PubMed ID: 20519652
[TBL] [Abstract][Full Text] [Related]
28. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
[TBL] [Abstract][Full Text] [Related]
29. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
30. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary?
Asahina A; Tamaki K
J Dermatol Sci; 2006 Oct; 44(1):1-9. PubMed ID: 16949255
[TBL] [Abstract][Full Text] [Related]
31. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
32. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
33. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness.
Cruz PD; Bergstresser PR
Dermatol Clin; 1990 Oct; 8(4):633-47. PubMed ID: 1979019
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
Enk AH; Angeloni VL; Udey MC; Katz SI
J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
[TBL] [Abstract][Full Text] [Related]
35. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes.
Kobayashi M; Yoshiki R; Sakabe J; Kabashima K; Nakamura M; Tokura Y
Br J Dermatol; 2009 Feb; 160(2):297-304. PubMed ID: 19016710
[TBL] [Abstract][Full Text] [Related]
36. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
[TBL] [Abstract][Full Text] [Related]
38. Multistep navigation of Langerhans/dendritic cells in and out of the skin.
Jakob T; Ring J; Udey MC
J Allergy Clin Immunol; 2001 Nov; 108(5):688-96. PubMed ID: 11692090
[TBL] [Abstract][Full Text] [Related]
39. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
Jolles S; Christensen J; Holman M; Klaus GB; Ager A
Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
